Preparation and Characterization of Antioxidant Nanoparticles Composed of Chitosan and Fucoidan for Antibiotics Delivery

被引:82
作者
Huang, Yi-Cheng [1 ]
Li, Rou-Ying [1 ]
机构
[1] Natl Taiwan Ocean Univ, Coll Life Sci, Dept Food Sci, Keelung 20224, Taiwan
关键词
chitosan; fucoidan; nanoparticle; antioxidant; antibiotic; delivery; IN-VITRO CHARACTERIZATION; PULMONARY DRUG-DELIVERY; DRY POWDER; BIODEGRADABLE NANOPARTICLES; SULFATED POLYSACCHARIDES; MICROSPHERES; HEPARIN; RELEASE; CELLS; CYTOTOXICITY;
D O I
10.3390/md12084379
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this study, we developed novel chitosan/fucoidan nanoparticles (CS/F NPs) using a simple polyelectrolyte self-assembly method and evaluated their potential to be antioxidant carriers. As the CS/F weight ratio was 5/1, the CS/F NPs were spherical and exhibited diameters of approximately 230-250 nm, as demonstrated by TEM. These CS/F NPs maintained compactness and stability for 25 day in phosphate-buffered saline (pH 6.0-7.4). The CS/F NPs exhibited highly potent antioxidant effects by scavenging 1,1-diphenyl-2-picrylhydrazyl (DPPH), reducing the concentration of intracellular reactive oxygen species (ROS) and superoxide anion (O-2(-)) in stimulated macrophages. The DPPH scavenging effect of CS/F NPs primarily derives from fucoidan. Furthermore, these CS/F NPs activated no host immune cells into inflammation-mediated cytotoxic conditions induced by IL-6 production and NO generation. The MTT cell viability assay revealed an absence of toxicity in A549 cells after exposure to the formulations containing 0.375 mg NPs/mL to 3 mg NPs/mL. Gentamicin (GM), an antibiotic, was used as a model drug for an in vitro releasing test. The CS/F NPs controlled the release of GM for up to 72 h, with 99% of release. The antioxidant CS/F NPs prepared in this study could thus be effective in delivering antibiotics to the lungs, particularly for airway inflammatory diseases.
引用
收藏
页码:4379 / 4398
页数:20
相关论文
共 55 条
[41]   Potential antioxidant capacity of sulfated polysaccharides from the edible marine brown seaweed Fucus vesiculosus [J].
Rupérez, P ;
Ahrazem, O ;
Leal, JA .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2002, 50 (04) :840-845
[42]  
Sanders NN, 2000, J PHARM SCI-US, V89, P835, DOI 10.1002/1520-6017(200007)89:7<835::AID-JPS1>3.0.CO
[43]  
2-6
[44]   SURFACTANT DISPLACES PARTICLES TOWARD THE EPITHELIUM IN AIRWAYS AND ALVEOLI [J].
SCHURCH, S ;
GEHR, P ;
HOF, VI ;
GEISER, M ;
GREEN, F .
RESPIRATION PHYSIOLOGY, 1990, 80 (01) :17-32
[45]   Comparison on In Vitro Characterization of Fucospheres and Chitosan Microspheres Encapsulated Plasmid DNA (pGM-CSF): Formulation Design and Release Characteristics [J].
Sezer, Ali Demir ;
Akbuga, Juelide .
AAPS PHARMSCITECH, 2009, 10 (04) :1193-1199
[46]   Particle engineering techniques for inhaled biopharmaceuticals [J].
Shoyele, Sunday A. ;
Cawthome, Simon .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (9-10) :1009-1029
[47]   Heparinized chitosan/poly(γ-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin [J].
Tang, Deh-Wei ;
Yu, Shu-Huei ;
Ho, Yi-Cheng ;
Mi, Fwu-Long ;
Kuo, Pi-Li ;
Sung, Hsing-Wen .
BIOMATERIALS, 2010, 31 (35) :9320-9332
[48]   Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: Modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers [J].
Ungaro, Francesca ;
d'Angelo, Ivana ;
Coletta, Ciro ;
Bianca, Roberta d'Emmanuele di Villa ;
Sorrentino, Raffaella ;
Perfetto, Brunella ;
Tufano, Maria Antonietta ;
Miro, Agnese ;
La Rotonda, Maria Immacolata ;
Quaglia, Fabiana .
JOURNAL OF CONTROLLED RELEASE, 2012, 157 (01) :149-159
[49]   Chitosan Derivatives with Antimicrobial, Antitumour and Antioxidant Activities - a Review [J].
Vinsova, Jarmila ;
Vavrikova, Eva .
CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (32) :3596-3607
[50]   Dry powder inhalation of colistin in cystic fibrosis patients: A single dose pilot study [J].
Westerman, E. M. ;
De Boer, A. H. ;
Le Brun, P. P. H. ;
Touw, D. J. ;
Roldaan, A. C. ;
Frijlink, H. W. ;
Heijerman, H. G. M. .
JOURNAL OF CYSTIC FIBROSIS, 2007, 6 (04) :284-292